| Proton Pump Inhibitor |
0 |
1 |
| Gastroesophageal Reflux Disease |
0 |
0.67 |
| Otolaryngology |
0 |
0.5 |
| Chronic Kidney Disease |
0 |
0.33 |
| Renal Failure |
0 |
0.33 |
| Idiopathic Pulmonary Fibrosis |
0 |
0.3 |
| Addiction |
0 |
0.18 |
| Barrett Esophagus |
0 |
0.18 |
| COVID-19 |
0 |
0.18 |
| Fractures |
0 |
0.18 |
| Inflammatory Bowel Disease |
0 |
0.18 |
| Medical Life |
0 |
0.18 |
| Patient Safety |
0 |
0.18 |
| Upper Gastrointestinal Hemorrhage |
0 |
0.13 |
| Eosinophilic Esophagitis |
0 |
0.1 |
| Erosive Esophagitis |
0 |
0.1 |
| Esophagitis |
0 |
0.09 |
| Esophagus |
0 |
0.09 |
| Gastrointestinal Hemorrhage |
0 |
0.09 |
| Renal Disease |
0 |
0.07 |
| Adverse Effects |
0 |
0.05 |
| Board Certification |
0 |
0.05 |
| Clinical Research |
0 |
0.05 |
| Dementia |
0 |
0.05 |
| Drug Withdrawal |
0 |
0.05 |
| Health Care Cost |
0 |
0.05 |
| Jobs |
0 |
0.05 |
| Kidney |
0 |
0.05 |
| Lung Fibrosis |
0 |
0.05 |
| Plantar |
0 |
0.05 |
| Primary Care |
0 |
0.05 |